Since our previous results demonstrated a higher expression of ATG7/ATG7 in NASH, we wanted to focus the analysis on the main parameters related to this advanced stage of NAFLD, such as portal and lobular inflammation, and hepatocellular ballooning. The gene discussed is ATG7; the disease is metabolic dysfunction-associated steatotic liver disease.